MDM2 and embryonal carcinoma: High levels of MDM2 seem to be an intrinsic characteristic of embryonal carcinoma, and, regardless of therapeutical response, all embryonal carcinomas show a pronounced MDM2 protein expression, without gene amplification [20]: other MDM2 up-regulation mechanisms, as enhanced gene translation and translocation, have been suggested [21, 22].